The aim of the present study was to evaluate the frequency of detection of Mogibacterium timidum in subgingival samples of subjects with generalized aggressive periodontitis (GAgP) and uncontrolled diabetic and non-diabetic subjects with generalized chronic periodontitis (GChP). 48 patients with GAgP, 50 nondiabetic and 39 uncontrolled (glycated hemoglobin >7%) type 2 diabetic subjects with GChP were enrolled in this study. Subgingival biofilm were collected from deep pockets (probing depth > 7 mm). After DNA extraction, M. timidum was detected by Nested Polymerase Chain Reaction and chi-square test was used to data analysis (p>0.05). There were no differences in the frequency of detection of M. timidum between subjects with GAgP (35%) and non-diabetic subjects with GChP (40%) (p>0.05). The frequency of detection of M. timidum was significantly higher in deep pockets of diabetic subjects with GChP (56%) when compared to GAgP (p<0.05), but similar to non-diabetic subjects with GChP (p>0.05). The frequency of detection of M. timidum was higher in subjects GChP presenting uncontrolled type 2 diabetes mellitus, when compared to GAgP subjects.
INTRODUCTION
In 2000, the new genus Mogibacterium was proposed to include the novel species Mogibacterium pumilum and Mogibacterium vescum, as well as the former Eubacterium timidum by taxonomic reassignment (16) . Members of the genus Mogibacterium are described as strictly anaerobic and asaccharolytic Gram-positive rod-shaped bacteria. Cells are non-motile, do not form spores and exhibit very poor growth in broth media. Mogibacterium timidum (formerly Eubacterium timidum (9)), nominated due to its slight or slow growth in clumps, is an example of this genera that are regular to slightly diphtheroid in shape. This bacterium has shown to be present in oral environments and to be involved in infectious oral 932 Casarin, R.C.V. et al.
M. timidum in subgingival biofilm diseases.
M. timidum was previously isolated from subgingival biofilm of periodontitis (9) . In addition, detection of M.
timidum increased as the severity of the clinical parameters of gingivitis increased (14) , suggesting that this species could contribute to the increased susceptibility of adults to gingivitis and periodontitis. Subsequently, Moore et al. (13) demonstrated the presence of M. timidum periodontal pockets of "juvenile" and chronic periodontitis (CP). Moreover, M.
timidum was also correlated to other forms of head and neck infections. Hill et al. (8) evaluated the microbial biodiversity of head and neck abscesses (Ludwig's angina) and acute lung and liver infections using culture and biochemical techniques, and identified M. timidum in many of the infected sites.
Although M. timidum has been shown to play an important role in periodontal disease, no study as of yet has compared the frequency of the detection of this bacterium between chronic and aggressive periodontitis (AgP). In addition, the levels of M. timidum in CP diabetic subjects, which present an increased risk for periodontitis and other infections (12), have not been previously evaluated. Diabetes mellitus (DM) and poor glycemic control are considered important risk factors for periodontitis and have exhibited a negative influence on subgingival microbiota (4, 10) . Therefore, the aim of this study was to evaluate the frequency of detection of M. timidum in subgingival samples of subjects with aggressive periodontitis (AgP) and uncontrolled type 2 diabetic and non-diabetic subjects with chronic periodontitis (ChP).
MATERIALS AND METHODS

Study population
Non-diabetic patients presenting generalized GAgP 
Clinical parameters
The following parameters were assessed at six sites of all teeth, excluding third molars (mesio-buccal, medio-buccal, disto-buccal, mesio-lingual, medio-lingual, disto-lingual), using a manual periodontal probe (UNC15, Hu-Friedy, Chicago, IL, USA): plaque index (PI), BoP, suppuration (SUP), PD (mm) and CAL (mm).
Experimental groups
Based on their glycemic and periodontal characteristics, the subjects were divided into one of the following groups:
GAgP (n=48), non-diabetic with GChP (50) and poorly controlled type 2 diabetic subjects with GChP (n=39)
M. timidum detection
Subgingival biofilm were collected from 2 deep pockets (PD > 7mm) per subject using a Gracey curette. Prior to sampling, supragingival plaque was removed with sterile cotton pellets and the sites were isolated with cotton rolls to avoid saliva contamination. DNA was extracted as previously described by Saito et al. (18) . After DNA extraction, the presence of M. timidum was determined by a Nested Polymerase Chain Reaction (Nested PCR). The outer and inner primers were based on Mayanagi et al. (11) . PCR products were then loaded on a 1% agarose gel stained with ethidium bromide and amplicons were detected under UV light.
Statistical Analysis
Demographic and clinical comparisons were performed by one way ANOVA. When there were significant differences by one way ANOVA, a pairwise comparison was performed by Tukey test. Gender distribution and M. timidum frequencies were compared using Chi-Square test. The level of significance was set at 5% for all statistical analysis. GAgP subjects were younger (27.6 ± 0.9 years) than nondiabetic (43.6±8.3 years) and diabetic subjects with GChP (56.5 ± 9.5 years). Hb1Ac levels in diabetic group was 10.4 ± 2.6% Table 1 . Demographic characteristics of the study population and full-mouth clinical parameters (mean ± SD). With this in mind, future studies should consider the significance of these results and identify the pathogenic pathway with which M. timidum could be associated. Thus, the next step to consider in future analysis is the virulence factors and pathogen-associated molecular patterns of this species, determining its real role in periodontal breakdown and identifying a therapeutic protocol to control its infection.
RESULTS
Clinical and demographic results
GAgP
Altogether, considering its possible virulence factors and its high prevalence in periodontitis biofilm, M. timidum harbors high potential to initiate and/or to increase the inflammatory response in periodontal tissues, especially in patients presenting DM with poor glycemic control.
